Slfn8 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of Slfn8, a protein belonging to the Schlafen (SLFN) family. The SLFN family plays significant roles in regulating cell proliferation, differentiation, and immune responses. Slfn8, in particular, is believed to be involved in modulating immune cell functions and may influence antiviral responses and cell cycle regulation. By affecting the expression and activity of Slfn8, these inhibitors aim to alter the pathways that control immune responses and cellular growth.
The mechanisms by which Slfn8 inhibitors function typically involve binding to critical domains of the Slfn8 protein, such as DNA-binding regions or enzymatic sites essential for its activity. This binding can prevent Slfn8 from interacting with its natural substrates or partners, thereby disrupting its role in cellular processes. By inhibiting Slfn8, these compounds can interfere with the normal signaling pathways that the protein influences, potentially leading to altered immune cell behavior and changes in cell proliferation rates. Research into Slfn8 inhibitors provides valuable insights into the molecular functions of Schlafen proteins and their impact on immune regulation and cellular dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which is involved in many signaling pathways, and can indirectly influence Slfn8-associated processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that affects various cellular processes and pathways that may interact with Slfn8. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, affecting stress and inflammatory pathways that can indirectly modulate Slfn8 functionality. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, influencing multiple cellular responses, potentially impacting Slfn8 interactions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can influence ERK pathways potentially related to Slfn8. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key player in cell growth and proliferation pathways, potentially influencing Slfn8. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits calcineurin, affecting NFAT signaling which can indirectly impact pathways linked to Slfn8. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Pan-caspase inhibitor that affects apoptosis processes, potentially influencing Slfn8. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Alters intracellular calcium levels, potentially impacting pathways related to Slfn8. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Affects various signaling pathways, potentially indirectly modulating Slfn8. | ||||||